In summary, this study shows that at 24 months after acute COVID-19 infection, patients still experience a high prevalence of PCC symptoms which correlate with inflammatory cytokine IL-1Ra and markers of endothelial dysfunction, especially ET-1. Here, EDN1 is linked to endothelial dysfunction.